v3.26.1
Combined and Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 26,249 $ 23,231
Restricted cash 19,359 24,320
Accounts receivable 15,108 12,245
Other assets 13,915 16,273
Property, plant and equipment, net 1,490 1,695
Other intangible assets, net 5,870 6,541
Goodwill 57,915 58,014
Total Assets 2,084,105 2,087,373
Liabilities    
Accounts payable and accrued expenses 89,899 95,208
Other liabilities 3,891 4,179
Current tax liabilities 933 855
Deferred tax liabilities 113,186 101,957
Notes payable, net 1,433,321 1,409,039
Total Liabilities 1,641,230 1,611,238
Stockholders' Equity    
Common Stock par value $0.0001 per share; 330,000,000 shares authorized as of March 31, 2026 and December 31, 2025 and 55,371,991 and 58,298,923 shares issued and outstanding as of March 31, 2026 and December 31, 2025 6 6
Additional paid-in capital (41,024) (49,549)
Retained earnings 486,548 522,632
Accumulated other comprehensive income (loss) (2,655) 3,046
Total stockholders' equity 442,875 476,135
Total Liabilities and Stockholders' Equity 2,084,105 2,087,373
Investments in receivables, net    
Assets    
Receivables, net 1,929,069 1,928,742
Credit card receivables    
Assets    
Receivables, net $ 15,130 $ 16,312